IL90309A - History of 6-Phenyl-3-) Piperazinylacil (- H, 3H (- PHRHNHSHBSHUI, VFB1) -2,4 T I, U T FAHRH RUEJU T VNFHKHO TU T I - Google Patents

History of 6-Phenyl-3-) Piperazinylacil (- H, 3H (- PHRHNHSHBSHUI, VFB1) -2,4 T I, U T FAHRH RUEJU T VNFHKHO TU T I

Info

Publication number
IL90309A
IL90309A IL9030989A IL9030989A IL90309A IL 90309 A IL90309 A IL 90309A IL 9030989 A IL9030989 A IL 9030989A IL 9030989 A IL9030989 A IL 9030989A IL 90309 A IL90309 A IL 90309A
Authority
IL
Israel
Prior art keywords
derivative
formula
denotes
compound
group
Prior art date
Application number
IL9030989A
Other languages
English (en)
Hebrew (he)
Other versions
IL90309A0 (en
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of IL90309A0 publication Critical patent/IL90309A0/xx
Publication of IL90309A publication Critical patent/IL90309A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL9030989A 1988-05-17 1989-05-16 History of 6-Phenyl-3-) Piperazinylacil (- H, 3H (- PHRHNHSHBSHUI, VFB1) -2,4 T I, U T FAHRH RUEJU T VNFHKHO TU T I IL90309A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8806568A FR2631625B1 (fr) 1988-05-17 1988-05-17 Derives de phenyl-6 piperazinylalkyl-3 1h,3h-pyrimidinedione-2,4, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
IL90309A0 IL90309A0 (en) 1989-12-15
IL90309A true IL90309A (en) 1994-02-27

Family

ID=9366355

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9030989A IL90309A (en) 1988-05-17 1989-05-16 History of 6-Phenyl-3-) Piperazinylacil (- H, 3H (- PHRHNHSHBSHUI, VFB1) -2,4 T I, U T FAHRH RUEJU T VNFHKHO TU T I

Country Status (20)

Country Link
US (1) US4950670A (es)
EP (1) EP0343050B1 (es)
JP (1) JPH02138266A (es)
KR (1) KR890017244A (es)
AT (1) ATE82969T1 (es)
AU (1) AU614135B2 (es)
CA (1) CA1327577C (es)
DE (1) DE68903680T2 (es)
DK (1) DK235889A (es)
ES (1) ES2045485T3 (es)
FI (1) FI892344A (es)
FR (1) FR2631625B1 (es)
GR (1) GR3007118T3 (es)
HU (1) HU201057B (es)
IE (1) IE891579L (es)
IL (1) IL90309A (es)
NO (1) NO172437C (es)
NZ (1) NZ229144A (es)
PT (1) PT90572B (es)
ZA (1) ZA893651B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2655988B1 (fr) * 1989-12-20 1994-05-20 Adir Cie Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
GB9012311D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser
JP3329534B2 (ja) * 1993-10-20 2002-09-30 株式会社東海理化電機製作所 シフトレバー装置
DE4425143A1 (de) * 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
US6306909B1 (en) 1997-03-12 2001-10-23 Queen's University At Kingston Anti-epileptogenic agents
PT957099E (pt) 1998-04-15 2003-02-28 Pfizer Prod Inc Carboxamidas heterociclicas
WO2001055119A2 (en) * 2000-01-25 2001-08-02 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
US7501429B2 (en) * 2001-04-11 2009-03-10 Queen's University At Kingston Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
CA2448160A1 (en) * 2001-05-25 2002-12-05 Queen's University At Kingston Heterocyclic beta-amino acids and their use as anti-epileptogenic agents
EP1724267B1 (en) 2004-02-26 2013-11-06 ASKA Pharmaceutical Co., Ltd. Pyrimidine derivative
CN102079743B (zh) * 2004-03-15 2020-08-25 武田药品工业株式会社 二肽基肽酶抑制剂
MXPA06013520A (es) * 2004-05-21 2007-01-26 Pfizer Prod Inc Tetrahironaftilpiperazinas como antagonistas, agonistas inversos y agonistas parciales de 5-ht1b.
KR102103768B1 (ko) 2018-04-04 2020-04-23 한양대학교 에리카산학협력단 5-ht2c 항진제로서의 활성을 가지는 광학 활성의 2-아미노-4-알콕시 피리미딘 유도체

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4625028A (en) * 1983-07-11 1986-11-25 The Upjohn Company 6-aryluracils and selected novel intermediates used in the preparation thereof
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
US4845221A (en) * 1988-04-15 1989-07-04 American Home Products Corporation Serotonergic substituted piperazinyl tetralins

Also Published As

Publication number Publication date
NZ229144A (en) 1990-10-26
FR2631625A1 (fr) 1989-11-24
JPH02138266A (ja) 1990-05-28
US4950670A (en) 1990-08-21
FR2631625B1 (fr) 1992-10-16
PT90572A (pt) 1989-11-30
ZA893651B (en) 1990-01-31
NO891949D0 (no) 1989-05-16
NO891949L (no) 1989-11-20
DK235889A (da) 1989-11-17
NO172437C (no) 1993-07-21
EP0343050B1 (fr) 1992-12-02
FI892344A0 (fi) 1989-05-16
AU3484389A (en) 1989-11-23
HU201057B (en) 1990-09-28
IL90309A0 (en) 1989-12-15
ES2045485T3 (es) 1994-01-16
DE68903680T2 (de) 1993-06-17
AU614135B2 (en) 1991-08-22
NO172437B (no) 1993-04-13
HUT50164A (en) 1989-12-28
PT90572B (pt) 1994-08-31
GR3007118T3 (es) 1993-07-30
FI892344A (fi) 1989-11-18
DK235889D0 (da) 1989-05-16
EP0343050A1 (fr) 1989-11-23
CA1327577C (en) 1994-03-08
DE68903680D1 (de) 1993-01-14
IE891579L (en) 1989-11-16
KR890017244A (ko) 1989-12-15
ATE82969T1 (de) 1992-12-15

Similar Documents

Publication Publication Date Title
US7098210B2 (en) 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
JP2020516666A (ja) アポトーシス誘発剤
JPH0314563A (ja) 新規4―フルオロ安息香酸誘導体
EP0100200A1 (en) 2-Substituted 4-amino-6,7-dimethoxyquinolines
BG107460A (bg) Производни на бензимидазола, тяхното получаване иприложението им в терапията
US4950670A (en) 6-phenyl-3-(piperazinyalalkyl)-2,4(1H,3H)-pyrimidinedione derivatives, their preparation and their application in therapy
NZ225706A (en) 2-((4-piperidyl)methyl)-1,2,3,4-tetrahydro-9h-pyrido(3,4-b) indole derivatives and their preparation
JPS61155358A (ja) ジアリール酪酸誘導体
US4748240A (en) Psychotropic bicyclic imides
NO161174B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-4 dihydropyridin-derivater.
CS405291A3 (en) 2-aminopyrimidine-4-carboxamide derivatives, process of their preparation and their application in therapy
JP4199668B2 (ja) Sst1アンタゴニスト活性を有するピペラジン誘導体
EP0784055A1 (en) Pyrimidinylpyrazole derivative
IE910747A1 (en) Derivatives of 4-(aminomethyl)-piperidine, their preparation¹and their therapeutic application
US4086353A (en) Certain azolinylamino (azolidinylimino) indazoles
DK156722B (da) Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater
JPH0225481A (ja) 2―[(4―ピペリジニル)メチル]―1,2,3,4―テトラヒドロイソキノリン誘導体、その製造方法およびその治療への適用
DK156064B (da) Analogifremgangsmaade til fremstilling af 2,4-(1h,3h)-quinazolindionderivater eller farmaceutisk acceptable syreadditionssalte deraf
CS248020B2 (en) Production method of the (+)-enantiomere or (+-)-racemical 4a,9b-trans-hexahydro-1h-pyridoindole derivatives
US5096900A (en) (4-piperidyl)methyl-2,3-dihydro-1h-isoindole and -2,3,4,5-tetrahydro-1h-benzazepine derivatives, their preparation and their application in therapy
AU641960B2 (en) Pyrimidine derivatives
CZ325196A3 (en) Derivatives of hydroximic acid, pharmaceutical compositions containing thereof, process of their preparation and intermediates used in the preparation process
US5081128A (en) 2,3-dihydro-1h-isoindole derivatives and their application in therapy
SK283489B6 (sk) Piperazinylalkyltiopyrimidínové deriváty, spôsob ich prípravy, farmaceutické kompozície s ich obsahom a ich použitie
FR2761068A1 (fr) Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique